39 results on '"Lv D"'
Search Results
2. 103P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of Chinese extensive-stage small cell lung cancer (ORIENTAL): Preliminary safety and efficacy results
3. LBA6 Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer: A multicentre, open-label, randomized phase III study
4. EP08.01-033 ML40471: Preliminary Analysis of Atezolizumab in Previously Treated Patients With Locally Advanced or Metastatic NSCLC
5. EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
6. EP14.01-016 Anlotinib Plus Toripalimab as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: a Single-Arm Phase II Study
7. Oxidation and coagulation/adsorption dual effects of ferrate (VI) pretreatment on organics removal and membrane fouling alleviation in UF process during secondary effluent treatment.
8. 3MO First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small cell lung cancer: Updated overall survival results from the phase III CameL-sq trial
9. Local application of the osteogenic inducer sustained-release system promotes early bone remodeling around titanium implants
10. MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
11. 1339P Efficacy and safety of MIL60, a bevacizumab biosimilar, in combination with paclitaxel/carboplatin in patients with advanced or recurrent non-squamous non-small cell lung cancer: A randomized, double-blind, multicenter phase III study
12. 1649P Anlotinib plus oral fluoropyrimidine S1 in treating patients with refractory or relapsed small cell lung cancer (SALTER TRIAL): An open-label, multicenter, single-arm, phase II trial
13. 1370TiP Befotertinib versus icotinib as first-line treatment in patients with advanced or metastatic EGFR-mutated non-small cell lung cancer: A multicenter, randomized, open-label, controlled phase III study
14. 60TiP ORIENTAL: An open label, multicenter, phase IIIb study of first-line durvalumab plus platinum-based chemotherapy in Chinese patients with extensive stage small cell lung cancer (ES-SCLC)
15. P76.28 Phase II Study of the Efficacy of the EGFR Inhibitor Mefatinib in Patients with Advanced EGFR-mutant NSCLC
16. P48.07 Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer
17. P21.10 Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)
18. P76.99 Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
19. P01.20 Short-Term Effificacy of Intrapleural Hyperthermic Perfusion for Malignant Pleural Effusion in Lung Carcinoma
20. New surgical treatment for a ruptured carotid artery near the skull base
21. P2.12-08 Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy
22. P1.01-90 Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC
23. P1.16-24 Detection of Plasma T790M Mutation After the First Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer in the Real World
24. P2.03-05 PHLPP1 Expression Through AKT and ERK Dual Signaling Pathways May Slow Down the Resistance to TKI in EGFR-Mutated Lung Adenocarcinoma
25. Primary Outcome of Postoperative Radiotherapy with Small Shape T Field in Esophageal Squamous Cell Carcinoma Patients
26. Shearing of γ’ particles in Co-base and Co-Ni-base superalloys
27. P1.15-32 Real World EGFR Mutation Profile from 1699 Non-Small Cell Lung Cancer Patients in Eastern China
28. P3.01-68 Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients with Advanced NSCLC Harboring EGFR Mutations
29. P2.17-30 Serum Lipoprotein(A) Correlates with the Effect of Endostar Combined with Concurrent Chemoradiotherapy in Patients with Locally Advanced LSCC
30. P3.11-26 Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer from a Single-Institution in China
31. P2.13-23 Osimertinib Treatment Result of Plasma T790M Positive in Different Clinical Failure Modes After First-Line EGFR TKI for EGFR Mutant NSCLC
32. Short-term memory defects and emotional changes following sleep deprivation in a rotenone treated Zebrafish model of Parkinson disease
33. The involvement of dopamine in pain modulation in the nucleus accumbens of 6-OHDA induced parkinson’s disease rat model
34. First complete genome sequence of canine bocavirus 2 in mainland China
35. Reappearance of buffalo-origin-like porcine circovirus type 2 strains in swine herds in southern China
36. Lower temperature deformation mechanisms in a γ″-strengthened Ni-base superalloy
37. Comparative proteomic analysis of salt response proteins in seedling roots of two wheat varieties
38. 6018 Multimodal preoperative evaluation in surgical decision-making for rectal cancer: a randomized controlled trial
39. Improved energy-utilizing efficiency by enzyme preparation supplement in broiler diets with different metabolizable energy levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.